News Brexit warning sounded on EU public health system The UK could find its ability to counter the threat of a ‘super-gonorrhoea’ and other infectious diseases hampered if the country loses access to the EU’s early warning health system, the B
News Novartis invests $100m in new malaria drugs Concerns are mounting over resistance to artemisinin
News Sanofi in talks with Evotec to out-licence antibiotic resear... Evotec to collaborate with academia, pharma and biotech on new antimicrobials
News ViiV's HIV drug could be used for TB co-infection patients Interim results suggest new treatment option for patients with TB and HIV
News Gilead takes 'HIV eradication' combo into clinic New approach tackles reserve of HIV within the body
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.